Gladman, D. D., Orbai, A., Gomez-Reino, J., Chang-Douglass, S., Leoncini, E., Burton, H. E., . . . Hsu, M. (2020). Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis. Curr Ther Res Clin Exp.
Style de citation ChicagoGladman, Dafna D., et al. "Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis." Curr Ther Res Clin Exp 2020.
Style de citation MLAGladman, Dafna D., et al. "Network Meta-Analysis of Tofacitinib, Biologic Disease-Modifying Antirheumatic Drugs, and Apremilast for the Treatment of Psoriatic Arthritis." Curr Ther Res Clin Exp 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.